GB1156973A - Quinazoline Derivatives - Google Patents

Quinazoline Derivatives

Info

Publication number
GB1156973A
GB1156973A GB29544/66A GB2954466A GB1156973A GB 1156973 A GB1156973 A GB 1156973A GB 29544/66 A GB29544/66 A GB 29544/66A GB 2954466 A GB2954466 A GB 2954466A GB 1156973 A GB1156973 A GB 1156973A
Authority
GB
United Kingdom
Prior art keywords
piperazinyl
alkyl
carbon atoms
quinazolines
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB29544/66A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1156973A publication Critical patent/GB1156973A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
GB29544/66A 1965-07-06 1966-06-30 Quinazoline Derivatives Expired GB1156973A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46987965A 1965-07-06 1965-07-06
US55570466A 1966-06-07 1966-06-07

Publications (1)

Publication Number Publication Date
GB1156973A true GB1156973A (en) 1969-07-02

Family

ID=27042885

Family Applications (1)

Application Number Title Priority Date Filing Date
GB29544/66A Expired GB1156973A (en) 1965-07-06 1966-06-30 Quinazoline Derivatives

Country Status (11)

Country Link
AT (3) AT300814B (de)
BE (1) BE683741A (de)
CH (1) CH473130A (de)
DE (1) DE1620138C3 (de)
DK (1) DK127599B (de)
ES (2) ES328686A1 (de)
FR (1) FR6396M (de)
GB (1) GB1156973A (de)
NO (1) NO119278B (de)
SE (1) SE342454B (de)
SG (1) SG12672G (de)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2120495A1 (de) * 1970-05-21 1971-12-02 Pfizer Inc., New York, N.Y. (V.St.A.) Neue Trialkoxychinazolin-Verbindungen und Verfahren zu ihrer Herstellung
DE2530894A1 (de) * 1974-07-25 1976-02-05 Pfizer Chinanzolinderivate
GB2142625A (en) * 1983-06-01 1985-01-23 Spofa Spojene Podniky Piperazino-quinazolines
WO1994005628A1 (en) 1992-08-31 1994-03-17 Acic (Canada) Inc. Synthesis of 2-substituted quinazoline compounds (such as terazosin) and meobentine and bethanidine and intermediates therefor
LT3038B (en) 1992-02-25 1994-09-25 Recordati Chem Pharm Heterobicyclic compounds
US5753641A (en) * 1991-03-20 1998-05-19 Merck & Co., Inc. Method of treatment for benign prostatic hyperplasia
WO2003055866A1 (en) * 2001-12-21 2003-07-10 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
JPWO2017150174A1 (ja) * 2016-03-04 2019-06-13 株式会社 シンスター・ジャパン ２，４−ジアミノキナゾリン誘導体又はその塩を有効成分として含有する医薬品組成物、及び、特定の構造を有する２，４−ジアミノキナゾリン誘導体

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159079A (da) * 1978-05-18 1979-11-19 Pfizer Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
RU2507198C1 (ru) * 2012-09-10 2014-02-20 Владимир Иванович Петров Производные хиназолина, обладающие ноотропной и антигипоксической активностью
RU2507199C1 (ru) * 2012-09-10 2014-02-20 Владимир Иванович Петров Производные хиназолина, обладающие антидепрессивной, анксиолитической и ноотропной активностью

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2120495A1 (de) * 1970-05-21 1971-12-02 Pfizer Inc., New York, N.Y. (V.St.A.) Neue Trialkoxychinazolin-Verbindungen und Verfahren zu ihrer Herstellung
DE2167157C2 (de) * 1970-05-21 1982-06-09 Pfizer Inc., 10017 New York, N.Y. 4-Substituierte-2-halogen-6,7,8-trimethoxychinazoline
DE2530894A1 (de) * 1974-07-25 1976-02-05 Pfizer Chinanzolinderivate
GB2142625A (en) * 1983-06-01 1985-01-23 Spofa Spojene Podniky Piperazino-quinazolines
US6046183A (en) * 1991-03-20 2000-04-04 Merck & Co., Inc. Method of synergistic treatment for benign prostatic hyperplasia
US5753641A (en) * 1991-03-20 1998-05-19 Merck & Co., Inc. Method of treatment for benign prostatic hyperplasia
LT3038B (en) 1992-02-25 1994-09-25 Recordati Chem Pharm Heterobicyclic compounds
US5675006A (en) * 1992-08-31 1997-10-07 Brantford Chemicals Inc. Methods of making ureas and guanidines, including, terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin, and bunazosin (exemplary of 2- substituted quinazoline compounds), and meobentine, and bethanidine and intermediates therefor
US5686612A (en) * 1992-08-31 1997-11-11 Brantford Chemicals Inc. Methods of making ureas and guanidines, including terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin, and bunazosin (exemplary of 2-substituted quinazoline compounds), and meobentine, and bethanidine and intermediates thereof
WO1994005628A1 (en) 1992-08-31 1994-03-17 Acic (Canada) Inc. Synthesis of 2-substituted quinazoline compounds (such as terazosin) and meobentine and bethanidine and intermediates therefor
US6080860A (en) * 1992-08-31 2000-06-27 Brantford Chemicalss Inc. Methods of making ureas and guanidines including, terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin and bunazosin (exemplary of 2-substituted quinazoline compounds), and meobentine, and bethanidine and intermediates therefor
WO2003055866A1 (en) * 2001-12-21 2003-07-10 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
JPWO2017150174A1 (ja) * 2016-03-04 2019-06-13 株式会社 シンスター・ジャパン ２，４−ジアミノキナゾリン誘導体又はその塩を有効成分として含有する医薬品組成物、及び、特定の構造を有する２，４−ジアミノキナゾリン誘導体

Also Published As

Publication number Publication date
ES339406A1 (es) 1968-07-16
AT289122B (de) 1971-04-13
DE1620138A1 (de) 1970-03-12
DK127599B (da) 1973-12-03
SE342454B (de) 1972-02-07
CH473130A (fr) 1969-05-31
DE1620138C3 (de) 1978-08-17
SG12672G (en) 1988-09-02
AT300814B (de) 1972-08-10
BE683741A (de) 1967-01-06
ES328686A1 (es) 1967-09-01
FR6396M (de) 1968-10-21
NO119278B (de) 1970-04-27
DE1620138B2 (de) 1977-12-15
AT289806B (de) 1971-05-10

Similar Documents

Publication Publication Date Title
US3635979A (en) Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
GB1156973A (en) Quinazoline Derivatives
US3511836A (en) 2,4,6,7-tetra substituted quinazolines
AU2016277367B2 (en) Aryl sulfonohydrazides
US10961256B2 (en) PRMT5 inhibitors
US20070135432A1 (en) Compounds, methods and compositions
US20090170849A1 (en) Quinazolinone derivatives having b-raf inhibitory activity
CZ20024178A3 (cs) Způsoby a kompozice využívající chinazoliny
EP1924573A1 (de) B-raf-inhibitoren
WO2007113557A1 (en) Substituted quinazolines with anti-cancer activity
HUT58707A (en) Process for producing diamino-pyrimidine derivatives and pharmaceutical compositions containing them
CN101801937A (zh) 喹唑啉酮化合物及其使用方法
WO1994005628A1 (en) Synthesis of 2-substituted quinazoline compounds (such as terazosin) and meobentine and bethanidine and intermediates therefor
EP0227450A2 (de) Substituierte 5,6-Dialkoxychinazolin-Derivate
US8859571B2 (en) Quinazoline compounds
US3748327A (en) Basically substituted 4(3h)-quinazolinone derivatives
Gheidari et al. The quinazoline-2, 4 (1H, 3H)-diones skeleton: A key intermediate in drug synthesis
US20080045708A1 (en) New Process for the Synthesis of Morpholinylbenzenes
US3322766A (en) 3-beta-(4-pyridyl) ethyl-2, 3-dihydro-4(1h)-quinazolinones
Ohno et al. Synthesis and Hypoglycemic Activity of 7, 8-Dihydro-6H-thiopyrano [3, 2-d] pyrimidine Derivatives and Related Compounds
Lee et al. 1, 4‐Dioxane‐fused 4‐anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase
EP3040337A1 (de) 2,6-di-stickstoff-haltiges substituiertes purinderivat und herstellungsverfahren, pharmazeutische zusammensetzung und verwendung davon
WO2007065940A1 (en) Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
US3525748A (en) Certain 2-amino-3-phenyl-3,4-dihydroquinazolin-4-ones
US10745380B2 (en) Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathies

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
423P Notice of intention to present a petition (sect. 23/1949)
423P Notice of intention to present a petition (sect. 23/1949)
EPO Patent for which application for extension of term has been made to the comptroller or the court
EPF Patent extended in pursuance of application for extension of term and in force
EPF Patent extended in pursuance of application for extension of term and in force
PE20 Patent expired after termination of 20 years